PRESS RELEASE
Aug 29, 2024
BioStem Technologies Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET
Aug 29, 2024
BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET
Aug 21, 2024
BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers
Aug 21, 2024
BioStem Technologies: A New Growth Star In Health Care
Aug 12, 2024
BioStem Technologies, Inc. (BSEM) Q2 2024 Earnings Call Transcript
Aug 12, 2024
BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
Aug 05, 2024
BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
Jul 16, 2024
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments
Jul 10, 2024
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers
Jun 26, 2024
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study